Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

3 Experts Discuss Bone Health

Thomas R. Collins  |  Issue: February 2018  |  February 18, 2018

Tridsanu Thopet / SHUTTERSTOCK.COM

Tridsanu Thopet / SHUTTERSTOCK.COM

SAN DIEGO—At the 2017 ACR/ARHP Annual Meeting Nov. 3–8, experts discussed improving bone health in the U.S., gave tips on bone health disorders in pediatrics and reviewed new translational science findings for joint conservation in early osteonecrosis.

E. Michael Lewiecki, MD, director of the New Mexico Clinical Research & Osteoporosis Center in Albuquerque, N.M., called on physicians to help improve osteoporosis care, which has declined over the past several years due factors that include fear of drug side effects, dual X-ray absorptiometry (DXA) reimbursement declines and competing guidelines.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

After more than 10 years of dropping hip fracture rates, the rate has plateaued over the past several years, leading to a sizable gap between the actual and projected numbers of 14,000 additional hip fractures and 2,800 additional deaths that could be attributed to fractures, all of which might have been prevented, Dr. Lewiecki said.

“This is why it’s now called a crisis,” he said. “My big audacious goal is to reduce the osteoporosis treatment gap from 80% to 20% in the next 10 years. I’d like to deputize each of you in this audience. I’d like to empower you to do something about this. And you can. There are things that we can all do to help.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Specifically, Dr. Lewiecki said physicians can:

  • Develop a fracture liaison service (FLS) system that identifies those at risk of secondary fracture and delivers the treatment they need. This typically involves an FLS coordinator (often a nurse practitioner or physician’s assistant) who uses software to track patients;
  • Improve DXA reimbursement and employ DXA best practices. “Poor DXA reimbursement leads to poor DXA quality,” he said, urging physicians to work to promote better reimbursement. He also called on physicians to bone up on best practices, with up-to-date DXA training, certification and possibly facility accreditation;
  • Treat to target. An American Society for Bone and Mineral Research-National Osteoporosis Foundation task force suggests treating to a target T score of -2.0, rather than -2.5, could increase confidence “considering the measurement error with the DXA test”; and
  • Knowledge-share through Project ECHO, which involves case-based discussions and brief didactic presentations via videoconference. The project now sports 139 hubs in 23 countries, covering more than 45 diseases, Dr. Lewiecki said.

Catherine Gordon, MD, MS, director of adolescent and transition medicine at Cincinnati Children’s Hospital in Cincinnati, discussed how to treat and manage pediatric patients with bone disorders, from primary osteogenesis imperfecta to secondary bone disorders, including juvenile idiopathic arthritis (JIA), glucocorticoid-induced osteoporosis and anorexia nervosa (AN).

Page: 1 2 3 | Single Page
Share: 

Filed under:Meeting ReportsOsteoarthritis and Bone Disorders Tagged with:ACR/ARHP Annual Meetingbone and jointJuvenile arthritisOsteoarthritisOsteonecrosis

Related Articles

    Diagnosis, Management of Medication-Induced Osteonecrosis of the Bone

    October 13, 2015

    Prior to the widespread use of bisphosphonates for the manage­ment of osteoporosis, multiple myeloma and metastatic cancer to the skeletal system, osteonecrosis of the jawbones was an infrequent condition seen after radiation for oral cancers (osteoradionecrosis) and in chronic odontogenic infections.1 Since the mid-2000s, osteonecrosis of the jawbones has been noted to occur as a…

    Reading Rheum

    May 1, 2009

    Handpicked Reviews of Contemporary Literature

    Zoledronic Acid vs. Oral Bisphosphonates: Osteoporosis Treatments & the Risk of Developing Osteonecrosis of the Jaw

    December 12, 2022

    A study from Amigues et al. found that bisphosphonate-associated osteonecrosis of the jaw is rare in patients with osteoporosis and may occur more often in patients treated with injectable zoledronic acid than in those treated with the oral bisphosphonates.

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences